PIM-Pointing a TRAIL for Cancer Cures - Kimberly S. Meza

Year
2026
Organisation
Brown University
Tags
Kidney Cancer
cancer biology
PIM1
TRAIL
Apoptosis
ONC201
targeted therapy
biomarkers
precision medicine
oncology
cancer research
cell signaling
Metastatic Cancer
drug development
preclinical research
Brown University
Renal Cell Carcinoma
molecular biology
cancer therapeutics
translational medicine
Summary

This research investigates a new targeted treatment strategy for kidney cancer by inhibiting the cancer-promoting protein PIM1 while enhancing TRAIL-mediated apoptosis. Together with the FDA-approved drug ONC201, this combination restores cancer cells' ability to self-destruct, offering a promising therapeutic approach now being evaluated in preclinical studies.